Pacira BioSciences, Inc. (PCRX)
$36.31-0.11%Close
BUYBULL · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.4B
- Beta
- 0.25
- P/E (TTM)
- 103.12
- Short % float
- 21.44%
- Days to cover
- 15.1
- SI change
- +6.8%
- 1W
- +46.65%
- 1M
- +47.12%
- vs SPY 1W
- +46.79%
- vs SPY 1M
- +44.62%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PCRX?
- LOPJLB’s latest quantitative signal on Pacira BioSciences, Inc. (PCRX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is PCRX in?
- Pacira BioSciences, Inc. (PCRX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Pacira BioSciences, Inc. (PCRX) do?
- Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers …